Re: The Effect of Testosterone on Cardiometabolic Risk Factors in Atorvastatin-Treated Men with Late-Onset Hypogonadism

J Urol. 2016 Jun;195(6):1855. doi: 10.1016/j.juro.2016.03.054. Epub 2016 Mar 17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Atorvastatin*
  • Cardiovascular Diseases
  • Hormone Replacement Therapy
  • Humans
  • Hypogonadism
  • Male
  • Risk Factors
  • Testosterone*

Substances

  • Testosterone
  • Atorvastatin